Learn how to interpret your PSMA-PET scan results, understand SUV metrics, and track metastatic prostate cancer treatment options and progress.

A 58-year-old businessman walks into a clinic for a routine health check. He feels fine. No pain, no urinary trouble, nothing ...

Theranostics combine PSMA imaging with targeted radiation therapy to help locate and treat advanced prostate cancer using the ...

For the hundreds of thousands of men who undergo radical prostatectomy each year, one question looms over every postoperative ...

For decades, the diagnosis of clinically significant prostate cancer has rested on an uncomfortable compromise.

A case report led by UCLA Health researchers highlights the importance of a multidisciplinary, evidence-based approach to ...

But new, targeted forms of treatment are available, and they are transforming the landscape of prostate cancer care. One of these newer treatments is called prostate-specific membrane antigen (PSMA) ...

Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver ...

A high PSA blood test can be worrying, but it cannot tell doctors for certain whether a man has prostate cancer. New research suggests a specialized scan could give doctors another important clue ...

India has 0.3 PET-CT scanners per million population, way below the World Health Organization standard of 2 and the American ...

Get latest articles and stories on Business at LatestLY. Ahmedabad (Gujarat) [India], September 29: Cancer treatment is ...

Genomic testing in high-risk prostate cancer remains underutilized nationally, driven by fragmented ordering and interpretive ...